Therapeutic Solutions Financials
| TSOI Stock | USD 0.0005 0.0001 16.67% |
Therapeutic |
Therapeutic Solutions Stock Summary
Therapeutic Solutions competes with Ensysce Biosciences, Aptorum Group, Alpha Cognition, Biomx, and Zura Bio. Therapeutic Solutions International, Inc. focuses on immune modulation for the treatment of various specific diseases. Therapeutic Solutions International, Inc. was founded in 2007 and is based in Elk City, Idaho. Therapeutic Solutions operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 3 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US8833781011 |
| Business Address | 701 Wild Rose |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.therapeuticsolutionsint.com |
| Phone | 760 295 7208 |
| Currency | USD - US Dollar |
Therapeutic Solutions Key Financial Ratios
Therapeutic Solutions' financial ratios allow both analysts and investors to convert raw data from Therapeutic Solutions' financial statements into concise, actionable information that can be used to evaluate the performance of Therapeutic Solutions over time and compare it to other companies across industries.| Return On Equity | -12.27 | |||
| Return On Asset | -0.76 | |||
| Beta | 1.49 |
Therapeutic Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Therapeutic Solutions's current stock value. Our valuation model uses many indicators to compare Therapeutic Solutions value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Therapeutic Solutions competition to find correlations between indicators driving Therapeutic Solutions's intrinsic value. More Info.Therapeutic Solutions International is rated third in return on equity category among its peers. It is rated fourth in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Therapeutic Solutions by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Therapeutic Solutions' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Therapeutic Solutions Systematic Risk
Therapeutic Solutions' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Therapeutic Solutions volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Therapeutic Solutions correlated with the market. If Beta is less than 0 Therapeutic Solutions generally moves in the opposite direction as compared to the market. If Therapeutic Solutions Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Therapeutic Solutions is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Therapeutic Solutions is generally in the same direction as the market. If Beta > 1 Therapeutic Solutions moves generally in the same direction as, but more than the movement of the benchmark.
Therapeutic Solutions December 2, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Therapeutic Solutions help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Therapeutic Solutions International. We use our internally-developed statistical techniques to arrive at the intrinsic value of Therapeutic Solutions International based on widely used predictive technical indicators. In general, we focus on analyzing Therapeutic Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Therapeutic Solutions's daily price indicators and compare them against related drivers.
| Downside Deviation | 13.98 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 50.79 | |||
| Value At Risk | (14.29) | |||
| Potential Upside | 16.67 |
Complementary Tools for Therapeutic Pink Sheet analysis
When running Therapeutic Solutions' price analysis, check to measure Therapeutic Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Therapeutic Solutions is operating at the current time. Most of Therapeutic Solutions' value examination focuses on studying past and present price action to predict the probability of Therapeutic Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Therapeutic Solutions' price. Additionally, you may evaluate how the addition of Therapeutic Solutions to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |